Headache News and Research

Latest Headache News and Research

Exploring microstructural brain abnormalities after mild COVID-19

Researchers assessed the functional and microstructural brain abnormalities, tiredness, and cognitive impairment after mild coronavirus disease 2019 (COVID-19).

19 Dec 2022

Recent surge in group A streptococcal infections among children in UK

In an editorial published in the journal New Microbes and New Infections, scientists have highlighted the possible reasons behind a sudden rise in cases of group A streptococcal infections among children in the United Kingdom and other European countries.

18 Dec 2022

CU study proves effectiveness of new multidrug treatment for patients with stage IV melanoma

A new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year clinical trial at the University of Colorado Cancer Center.

16 Dec 2022

Rehabilitation program for people with long COVID shows 'impressive' results

A rehabilitation program that helps people with long COVID reduce their symptoms and increase activity levels has shown "impressive" results, say scientists.

16 Dec 2022

Trial results confirm the safety of three different Ebola vaccine regimens

Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification against the Zaire ebolavirus species, it is essential to pursue and intensify efforts to supplement the available data to develop a safe and effective Ebola vaccine strategies in adults and children alike.

16 Dec 2022

Study: People with cluster headaches may be more likely to have other medical conditions

People with cluster headaches may be more than three times more likely to have other medical conditions such as heart disease, mental disorders and other neurologic diseases, according to a study published in the December 14, 2022, online issue of Neurology®, the medical journal of the American Academy of Neurology.

16 Dec 2022

New system based on AI enables mass detection of Covid cases with a sensitivity of 97%

Washing your hands with hydroalcoholic gel, smelling it and using a QR code to answer a short questionnaire.

15 Dec 2022

The UK's growing burden of long-COVID

Long COVID symptoms are more common in females and White identifying individuals between the ages of 35-49 years, as well as the disabled.

15 Dec 2022

The therapeutic effects and safety of psychedelics

Psychedelics are reported to have rapid-onset and long-lasting therapeutic benefits after a single or few doses.

14 Dec 2022

COVID-19 vaccination temporarily alters heart rate variability

HRV parameters after COVID-19 vaccination show significant short-term changes that may persist for up to three days until ultimately returning to baseline.

12 Dec 2022

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab-;a novel, patient-tailored monoclonal antibody therapy-;showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in The Lancet.

12 Dec 2022

What are the patterns of symptoms and risk factors for Long COVID among SARS-CoV-2 infected individuals?

Researchers explored the indicators of long COVID symptoms.

12 Dec 2022

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

Patients taking efgartigimod, a drug being studied for use to treat chronic primary immune thrombocytopenia (ITP), exhibited a significantly greater improvement in platelet counts which are essential to clotting and stopping bleeding, compared to those taking a placebo, according to results reported from the ADVANCE IV clinical trial, which was conducted globally, including at Georgetown University Medical Center.

12 Dec 2022

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

Patients with localized, hormone receptor-positive, HER2-low breast cancer treated with trastuzumab deruxtecan (T-DXd, Enhertu) in the neoadjuvant setting had an overall response rate of 75 percent in the absence of anastrozole and 63 percent in combination with anastrozole, according to results from the phase II TRIO-US B-12 TALENT trial presented at the San Antonio Breast Cancer Symposium, held December 6-10, 2022.

7 Dec 2022

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

The Pfizer-BioNTech mRNA-based COVID-19 vaccine may increase the risk of menstrual disturbances in adolescent girls in their first cycle after vaccination.

6 Dec 2022

Trial shows acoziborole drug clears body of African sleeping sickness parasites

Researchers evaluate the efficacy and safety of an oral antimicrobial drug acoziborole in patients with human African trypanosomiasis.

4 Dec 2022

Study reveals the widespread impact of pandemic on long COVID patients and people with other illnesses

Long COVID patients can experience many of the same lingering negative effects on their physical, mental, and social well-being as those experienced by people who become ill with other, non-COVID illnesses, new research suggests.

1 Dec 2022

Monkeypox renamed "mpox" in an effort to combat stigma

WHO announces that the monkeypox virus will now be referred to as “mpox” in an effort to reduce the stigmatization of this condition.

29 Nov 2022

Study finds possible shared predisposition between migraine and upper extremity nerve compression syndromes

Patients who undergo surgery for carpal tunnel syndrome and other upper extremity nerve compression syndromes are more likely to have a diagnosis of migraine headaches, reports a study in the December issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

29 Nov 2022

Pioneering new medical imaging solutions

In this interview, News-Medical talks to Allen Lee from American Portwell Technology, about their work for the company and how they have become a leading provider of medical equipment and medical imaging equipment in particular.

From American Portwell Technology, Inc 29 Nov 2022

Headache News and Research

Latest Headache News and Research

Exploring microstructural brain abnormalities after mild COVID-19

Recent surge in group A streptococcal infections among children in UK

CU study proves effectiveness of new multidrug treatment for patients with stage IV melanoma

Rehabilitation program for people with long COVID shows 'impressive' results

Trial results confirm the safety of three different Ebola vaccine regimens

Study: People with cluster headaches may be more likely to have other medical conditions

New system based on AI enables mass detection of Covid cases with a sensitivity of 97%

The UK's growing burden of long-COVID

The therapeutic effects and safety of psychedelics

COVID-19 vaccination temporarily alters heart rate variability

Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

What are the patterns of symptoms and risk factors for Long COVID among SARS-CoV-2 infected individuals?

Study shows potential benefits of efgartigimod as a treatment for immune thrombocytopenia

Study reports overall response of HER2-low breast cancer patients to neoadjuvant T-DXd treatment

COVID-19 vaccination may cause temporary menstrual disturbances in adolescent girls

Trial shows acoziborole drug clears body of African sleeping sickness parasites

Study reveals the widespread impact of pandemic on long COVID patients and people with other illnesses

Monkeypox renamed "mpox" in an effort to combat stigma

Study finds possible shared predisposition between migraine and upper extremity nerve compression syndromes

Pioneering new medical imaging solutions

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Headache News and Research

Latest Headache News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in